Galen buys licence for generic contraception

Northern pharmaceutical company Galen Holdings has said it bought an exclusive licence for a generic version of Galen's Ovcon 35 oral contraceptive from Barr Pharmaceuticals, for €19m

Galen buys licence for generic contraception

Northern pharmaceutical company Galen Holdings has said it bought an exclusive licence for a generic version of Galen's Ovcon 35 oral contraceptive from Barr Pharmaceuticals, for €19m

(€15.74m).

You have reached your article limit. Already a subscriber? Sign in

Continue reading for €5

Unlock unlimited access and exclusive benefits

More in this section

The Business Hub

Newsletter

News and analysis on business, money and jobs from Munster and beyond by our expert team of business writers.

Cookie Policy Privacy Policy Brand Safety FAQ Help Contact Us Terms and Conditions

© Examiner Echo Group Limited